MOXIE DWIGHT (SVP, GC & Secretary) sold 5.6% of their position (8.13K shares) of REVANCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $41.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2024ACC: 0001479290-24-000067
Officer· SVP, GC & Secretary
Since Feb 2020
-11.39K
Net shares
Net seller
$58.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.27K
Price / share
$5.30
Trade value
$17.34K
% of position
2.2%
3/15/2024
149.21K→145.94K
Common Stock
Direct
Shares
−8.13K
Price / share
$5.04
Trade value
$40.97K
% of position
5.6%
3/18/2024
145.94K→137.81K
Total
Net shares
−11.39K
Net value
-$58.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2024 | F · Tax Withholding | −3.27K | $5.30 | $17.34K | 2.2% | 149.21K | 145.94K |
| Common Stock Direct | 3/18/2024 | S · Sale | −8.13K | $5.04 | $40.97K | 5.6% | 145.94K | 137.81K |
| Total | −11.39K | -$58.31K | ||||||
Derivative Transactions0
No derivative transactions reported